109 related articles for article (PubMed ID: 18661187)
1. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
2. The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.
Li Y; Cai G; Yuan S; Jun Y; Li N; Wang L; Chen F; Ling R; Yun J
Am J Transl Res; 2015; 7(1):120-7. PubMed ID: 25755834
[TBL] [Abstract][Full Text] [Related]
3. Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target.
Crispi S; Calogero RA; Santini M; Mellone P; Vincenzi B; Citro G; Vicidomini G; Fasano S; Meccariello R; Cobellis G; Menegozzo S; Pierantoni R; Facciolo F; Baldi A; Menegozzo M
PLoS One; 2009 Sep; 4(9):e7016. PubMed ID: 19753302
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.
Leung SY; Chen X; Chu KM; Yuen ST; Mathy J; Ji J; Chan AS; Li R; Law S; Troyanskaya OG; Tu IP; Wong J; So S; Botstein D; Brown PO
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16203-8. PubMed ID: 12456890
[TBL] [Abstract][Full Text] [Related]
5. miR-181 suppresses metastasis via MMP-14.
Roth E; Cao J
Aging (Albany NY); 2015 Oct; 7(10):740-1. PubMed ID: 26527609
[No Abstract] [Full Text] [Related]
6. Genomic analysis of matrix metalloproteinases affecting the prognosis and immunogenic profile of gastric cancer.
Yuan C; Yuan J; Xiao H; Li H; Jiang Y; Zhai R; Zhai J; Xing H; Huang J
Front Genet; 2023; 14():1128088. PubMed ID: 37144126
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer.
He L; Kang Q; Chan KI; Zhang Y; Zhong Z; Tan W
Front Immunol; 2022; 13():1093990. PubMed ID: 36776395
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Circulating Biomarkers of Gastric Cancer.
Jelski W; Mroczko B
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886934
[TBL] [Abstract][Full Text] [Related]
9. Leptin stimulates migration and invasion and maintains cancer stem‑like properties in gastric cancer cells.
Park KB; Kim EY; Chin H; Yoon DJ; Jun KH
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866593
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells: biology and clinical significance.
Lin D; Shen L; Luo M; Zhang K; Li J; Yang Q; Zhu F; Zhou D; Zheng S; Chen Y; Zhou J
Signal Transduct Target Ther; 2021 Nov; 6(1):404. PubMed ID: 34803167
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells and TWIST Expression in Patients with Metastatic Gastric Cancer: A Preliminary Study.
Jhi JH; Kim GH; Park SJ; Kim DU; Lee MW; Lee BE; Kwon CH; Cho YK
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640500
[TBL] [Abstract][Full Text] [Related]
12. Emerging Role of Circulating Tumor Cells in Gastric Cancer.
Thanh Huong P; Gurshaney S; Thanh Binh N; Gia Pham A; Hoang Nguyen H; Thanh Nguyen X; Pham-The H; Tran PT; Truong Vu K; Xuan Duong N; Pelucchi C; La Vecchia C; Boffetta P; Nguyen HD; Luu HN
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183503
[TBL] [Abstract][Full Text] [Related]
13. Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer.
Dong Z; Sun X; Xu J; Han X; Xing Z; Wang D; Ge J; Meng L; Xu X
Med Sci Monit; 2019 Oct; 25():7770-7783. PubMed ID: 31619663
[TBL] [Abstract][Full Text] [Related]
14. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
Mathai RA; Vidya RVS; Reddy BS; Thomas L; Udupa K; Kolesar J; Rao M
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30889786
[TBL] [Abstract][Full Text] [Related]
15. Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer.
Kurashige J; Yokobori T; Mima K; Sawada G; Takahashi Y; Ueo H; Takano Y; Matsumura T; Uchi R; Eguchi H; Sudo T; Sugimachi K; Mori M; Baba H; Mimori K
Oncol Lett; 2019 Feb; 17(2):2393-2399. PubMed ID: 30675305
[TBL] [Abstract][Full Text] [Related]
16. High serum MMP-14 predicts worse survival in gastric cancer.
Kasurinen A; Tervahartiala T; Laitinen A; Kokkola A; Sorsa T; Böckelman C; Haglund C
PLoS One; 2018; 13(12):e0208800. PubMed ID: 30532247
[TBL] [Abstract][Full Text] [Related]
17. MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management.
Morcillo MÁ; García de Lucas Á; Oteo M; Romero E; Magro N; Ibáñez M; Martínez A; Garaulet G; Arroyo AG; López-Casas PP; Hidalgo M; Mulero F; Martínez-Torrecuadrada J
Contrast Media Mol Imaging; 2018; 2018():8382148. PubMed ID: 30224904
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells.
Li TT; Liu H; Yu J; Shi GY; Zhao LY; Li GX
World J Gastroenterol; 2018 Jun; 24(21):2236-2246. PubMed ID: 29881233
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating tumor cells in blood from patients with gastric cancer.
Arigami T; Uenosono Y; Yanagita S; Okubo K; Kijima T; Matsushita D; Amatatsu M; Kurahara H; Maemura K; Natsugoe S
Ann Gastroenterol Surg; 2017 Apr; 1(1):60-68. PubMed ID: 29863113
[TBL] [Abstract][Full Text] [Related]
20. Molecular background of the regional lymph node metastasis of gastric cancer.
Zhu T; Hu X; Wei P; Shan G
Oncol Lett; 2018 Mar; 15(3):3409-3414. PubMed ID: 29556271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
